HRT Financial’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
205,170
+67,902
| +49% | +$36.7K | ﹤0.01% | 1886 |
|
|
2025
Q1 | $90K | Buy |
+137,268
| New | +$90K | ﹤0.01% | 1935 |
|
|
2024
Q3 | – | Sell |
-264,441
| Closed | -$94K | – | 2843 |
|
|
2024
Q2 | $94K | Buy |
+264,441
| New | +$94K | ﹤0.01% | 1596 |
|
|
2024
Q1 | – | Sell |
-72,177
| Closed | -$39K | – | 2827 |
|
|
2023
Q4 | $39K | Buy |
72,177
+20,383
| +39% | +$11K | ﹤0.01% | 1814 |
|
|
2023
Q3 | $31K | Sell |
51,794
-690,012
| -93% | -$413K | ﹤0.01% | 1814 |
|
|
2023
Q2 | $964K | Buy |
741,806
+257,655
| +53% | +$335K | 0.01% | 904 |
|
|
2023
Q1 | $852K | Buy |
+484,151
| New | +$852K | 0.01% | 970 |
|
|
2022
Q3 | – | Sell |
-120,316
| Closed | -$498K | – | 3252 |
|
|
2022
Q2 | $498K | Buy |
+120,316
| New | +$498K | 0.01% | 1530 |
|
|
2022
Q1 | – | Sell |
-76,247
| Closed | -$571K | – | 3467 |
|
|
2021
Q4 | $571K | Buy |
76,247
+37,854
| +99% | +$283K | ﹤0.01% | 1457 |
|
|
2021
Q3 | $345K | Sell |
38,393
-45,362
| -54% | -$408K | ﹤0.01% | 2095 |
|
|
2021
Q2 | $1M | Buy |
+83,755
| New | +$1M | 0.01% | 1062 |
|
|
2021
Q1 | – | Sell |
-19,058
| Closed | -$297K | – | 2878 |
|
|
2020
Q4 | $297K | Buy |
19,058
+8,729
| +85% | +$136K | 0.01% | 1222 |
|
|
2020
Q3 | $97K | Buy |
+10,329
| New | +$97K | ﹤0.01% | 1454 |
|
|
2019
Q4 | – | Sell |
-20,351
| Closed | -$184K | – | 1499 |
|
|
2019
Q3 | $184K | Buy |
+20,351
| New | +$184K | 0.01% | 1063 |
|
|
2015
Q3 | – | Sell |
-11,400
| Closed | -$126K | – | 170 |
|
|
2015
Q2 | $126K | Buy |
+11,400
| New | +$126K | 0.06% | 149 |
|